查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1612820

带因者筛检市场：按类型、病理学、技术、最终用户分类 - 2025-2030 年全球预测

Carrier Screening Market by Type (Expanded Carrier Screening, Targeted Disease Carrier Screening), Medical Condition (Hematological Conditions, Neurological Conditions, Pulmonary Conditions), Technology, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，带因者筛检市场价值为30.7亿美元，预计到2024年将达到35.2亿美元，复合年增长率为14.93%，预计到2030年将达到81.3亿美元。

携带者筛检是一种基因检测方法，用于确定个体是否是可遗传给后代的特定基因突变的携带者。它可以识别体染色体隐性遗传和 X 连锁疾病的携带者，并为计划生育提供重要资讯。携带者筛检的必要性源自于预防遗传疾病传播的可能性，使其成为预防医学和生殖计画的重要工具。它可以帮助准父母在受孕前和产前情况下做出明智的生殖选择。最终用途主要是医院、诊断实验室和私人诊所。

主要市场统计
基准年[2023] 30.7亿美元
预测年份 [2024] 35.2亿美元
预测年份 [2030] 81.3亿美元
复合年增长率（%） 14.93%

带因者筛检市场主要是由人们对遗传疾病的认识不断提高、基因检测技术的进步以及遗传患者病率上升所推动的。关键的成长要素包括次世代定序(NGS) 技术的整合，该技术可提供更广泛、更准确的遗传变异分析。远端医疗和家庭检测套组的扩展提供了新的机会，为用户提供了更广泛的存取和便利。为了利用这些机会，公司应该考虑投资策略联盟并提高测试的成本效率。

然而，市场面临测试成本上升、道德考量和监管挑战等限制。假阳性和假阴性的可能性可能会造成意想不到的道德困境并影响市场成长。此外，接收测试结果和接受遗传咨询的需要增加了复杂性和成本。为了促进创新，重要的是要专注于开发更便宜的筛检技术，提高测试准确性，并增强鼓励消费者参与的使用者友善介面。基因治疗和编辑技术CRISPR的研究也可能为未来的成长提供一条道路。携带者筛检市场的本质是动态和不断发展的，其特点是技术的快速进步和监管的开拓。投资于患者教育计划以提高潜在用户的认识和接受度可以促进业务成长。

市场动态：揭示快速发展的职业筛检市场的关键市场洞察

供需的动态交互作用正在改变职业筛检市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 遗传病患病率上升，注重早期发现与预防
    • 老年人口增加，染色体异常风险高
    • 增加对卫生基础设施的投资和政府管理遗传疾病的努力
  • 市场限制因素
    • 缺乏熟练的专业人员和专业服务
  • 市场机会
    • POC诊断的新改进
    • 携带者筛检的技术进步
  • 市场问题
    • 存在不统一的标准和指南

波特的五力：驾驭职业筛检市场的策略工具

波特的五力架构是了解职业筛检市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解职业筛检市场的外部影响

外部宏观环境因素在塑造职业筛检市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解职业筛检市场的竞争格局

职业筛检市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：营运商筛检市场供应商绩效评估

FPNV定位矩阵是评估营运商筛检市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：规划职涯筛检市场的成功之路

职业筛检市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争格局中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 遗传性疾病增加，重视早期发现与预防
      • 人口老化加剧和染色体异常的高风险
      • 增加对卫生基础设施的投资和政府管理遗传疾病的倡议
    • 抑制因素
      • 缺乏熟练的专业人员和专业服务
    • 机会
      • POC诊断的新改进
      • 携带者筛检的技术进步
    • 任务
      • 存在不统一的标准和指南
  • 市场区隔分析
    • 类型：扩展携带者筛检(ECS) 提供遗传健康和状况的广泛概述
    • 最终使用者：医院携带者筛检应用的演变
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章职业筛检市场：依类型

  • 介绍
  • 扩大携带者筛检
    • 客製化面板测试
    • 预先设计的面板测试
  • 目标疾病携带者筛检

第七章 带因者筛检市场：依医疗状况分类

  • 介绍
  • 血液疾病
  • 神经系统疾病
  • 肺部疾病

第八章职业筛检市场：依技术分类

  • 介绍
  • DNA序列分析
  • 微阵列
  • 聚合酵素链锁反应

第九章职业筛检市场：依最终使用者分类

  • 介绍
  • 医院
  • 医生办公室和诊所
  • 参考实验室

第十章 美洲业者筛检市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太职业筛检市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的职业筛检市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Invitae 完成向 Natera 出售生殖健康资产
    • Fulgent Genetics 宣布推出新的 Beacon787 扩展带因者筛检小组
    • Bio-Techne 和 Oxford Nanopore Technologies 合作将创新的生殖医学和带因者筛检解决方案推向市场
  • 战略分析和建议

公司名单

  • 23Andme Inc.
  • Abbott Laboratories
  • Ambry Genetics Corporation by Konica Minolta, Inc.
  • Asper Biogene
  • Autogenomics Inc. by Prescient Medicine Holdings Inc.
  • BGI Genomics Co., Ltd.
  • Biora Therapeutics, Inc.
  • CENTOGENE NV
  • Danaher Corporation
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Fulgent Genetics, Inc.
  • Gene by Gene, Ltd. by myDNA Inc.
  • GeneDx Holdings Corp.
  • Illumina Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Luminex Corporation by DiaSorin Company
  • MedGenome Labs Ltd.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • OPKO Health, Inc.
  • Otogenetics Corporation
  • Quest Diagnostics Inc.
  • Thermo Fisher Scientific Inc.
  • TRUE HEALTH LABS
Product Code: MRR-034230D3E2DE

The Carrier Screening Market was valued at USD 3.07 billion in 2023, expected to reach USD 3.52 billion in 2024, and is projected to grow at a CAGR of 14.93%, to USD 8.13 billion by 2030.

Carrier screening is a genetic testing procedure used to determine if an individual is a carrier of a specific genetic mutation that could potentially be passed on to their offspring. Its scope extends to identifying carriers of autosomal recessive and X-linked genetic disorders, providing vital information for family planning. The necessity of carrier screening arises from its potential to prevent the transmission of genetic disorders, making it an essential tool in preventive healthcare and reproductive planning. It finds applications in pre-pregnancy and prenatal contexts, aiding prospective parents in making informed reproductive choices. The end-use scope primarily involves hospitals, diagnostic laboratories, and private clinics.

KEY MARKET STATISTICS
Base Year [2023] USD 3.07 billion
Estimated Year [2024] USD 3.52 billion
Forecast Year [2030] USD 8.13 billion
CAGR (%) 14.93%

The market for carrier screening is primarily driven by increasing awareness of genetic disorders, advancements in genetic testing technologies, and the rising prevalence of genetic conditions. Key growth factors include the integration of next-generation sequencing (NGS) technologies that offer a broader and more accurate analysis of genetic mutations. The expansion of telehealth and at-home testing kits provides new opportunities, enabling wider accessibility and convenience for users. Companies should consider investing in strategic collaborations and improving the cost-efficiency of tests to tap into these opportunities.

However, the market faces limitations such as high costs of testing, ethical considerations, and regulatory challenges. The potential of false positives or negatives can result in unforeseen ethical dilemmas, impacting market growth. Moreover, the need for genetic counseling following test results adds to the complexity and cost. To foster innovation, focusing on developing more affordable screening technologies, improving test accuracy, and enhancing user-friendly interfaces for consumer engagement is crucial. Researching into gene therapy and editing techniques CRISPR could also provide pathways for future growth. The nature of the carrier screening market is dynamic and evolving, characterized by rapid technological advancements and regulatory developments. Business growth can be bolstered by investing in patient education initiatives to enhance awareness and acceptance among potential users.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Carrier Screening Market

The Carrier Screening Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of inherited diseases and focus on early disease detection and prevention
    • Rising geriatric population and high risk of chromosomal abnormalities
    • Increasing investment in healthcare infrastructure and government initiatives for the management of genetic disorders
  • Market Restraints
    • Dearth of skilled professionals and professional services
  • Market Opportunities
    • Emerging improvements in POC diagnostics
    • Technological advancements in carrier screening
  • Market Challenges
    • Presence of non-uniform standards and guidelines

Porter's Five Forces: A Strategic Tool for Navigating the Carrier Screening Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Carrier Screening Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Carrier Screening Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Carrier Screening Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Carrier Screening Market

A detailed market share analysis in the Carrier Screening Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Carrier Screening Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Carrier Screening Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Carrier Screening Market

A strategic analysis of the Carrier Screening Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Carrier Screening Market, highlighting leading vendors and their innovative profiles. These include 23Andme Inc., Abbott Laboratories, Ambry Genetics Corporation by Konica Minolta, Inc., Asper Biogene, Autogenomics Inc. by Prescient Medicine Holdings Inc., BGI Genomics Co., Ltd., Biora Therapeutics, Inc., CENTOGENE N.V., Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., Gene by Gene, Ltd. by myDNA Inc., GeneDx Holdings Corp., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation by DiaSorin Company, MedGenome Labs Ltd., Myriad Genetics, Inc., Natera, Inc., OPKO Health, Inc., Otogenetics Corporation, Quest Diagnostics Inc., Thermo Fisher Scientific Inc., and TRUE HEALTH LABS.

Market Segmentation & Coverage

This research report categorizes the Carrier Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Expanded Carrier Screening and Targeted Disease Carrier Screening. The Expanded Carrier Screening is further studied across Customized Panel Testing and Predesigned Panel Testing.
  • Based on Medical Condition, market is studied across Hematological Conditions, Neurological Conditions, and Pulmonary Conditions.
  • Based on Technology, market is studied across DNA Sequencing, Microarrays, and Polymerase Chain Reaction.
  • Based on End-User, market is studied across Hospitals, Physician Offices & Clinics, and Reference Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of inherited diseases and focus on early disease detection and prevention
      • 5.1.1.2. Rising geriatric population and high risk of chromosomal abnormalities
      • 5.1.1.3. Increasing investment in healthcare infrastructure and government initiatives for the management of genetic disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Dearth of skilled professionals and professional services
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging improvements in POC diagnostics
      • 5.1.3.2. Technological advancements in carrier screening
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of non-uniform standards and guidelines
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Expanded carrier screening (ECS) offers a wide overview of genetic health and conditions
    • 5.2.2. End-User: Evolving application of carrier screening in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Carrier Screening Market, by Type

  • 6.1. Introduction
  • 6.2. Expanded Carrier Screening
    • 6.2.1. Customized Panel Testing
    • 6.2.2. Predesigned Panel Testing
  • 6.3. Targeted Disease Carrier Screening

7. Carrier Screening Market, by Medical Condition

  • 7.1. Introduction
  • 7.2. Hematological Conditions
  • 7.3. Neurological Conditions
  • 7.4. Pulmonary Conditions

8. Carrier Screening Market, by Technology

  • 8.1. Introduction
  • 8.2. DNA Sequencing
  • 8.3. Microarrays
  • 8.4. Polymerase Chain Reaction

9. Carrier Screening Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Physician Offices & Clinics
  • 9.4. Reference Laboratories

10. Americas Carrier Screening Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Carrier Screening Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Carrier Screening Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Invitae Completes Sale of Reproductive Health Assets to Natera
    • 13.3.2. Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel
    • 13.3.3. Bio-Techne and Oxford Nanopore Technologies Partner to Bring Innovative Reproductive Health and Carrier Screening Solutions to the Market
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 23Andme Inc.
  • 2. Abbott Laboratories
  • 3. Ambry Genetics Corporation by Konica Minolta, Inc.
  • 4. Asper Biogene
  • 5. Autogenomics Inc. by Prescient Medicine Holdings Inc.
  • 6. BGI Genomics Co., Ltd.
  • 7. Biora Therapeutics, Inc.
  • 8. CENTOGENE N.V.
  • 9. Danaher Corporation
  • 10. Eurofins Scientific
  • 11. F. Hoffmann-La Roche Ltd.
  • 12. Fulgent Genetics, Inc.
  • 13. Gene by Gene, Ltd. by myDNA Inc.
  • 14. GeneDx Holdings Corp.
  • 15. Illumina Inc.
  • 16. Invitae Corporation
  • 17. Laboratory Corporation of America Holdings
  • 18. Luminex Corporation by DiaSorin Company
  • 19. MedGenome Labs Ltd.
  • 20. Myriad Genetics, Inc.
  • 21. Natera, Inc.
  • 22. OPKO Health, Inc.
  • 23. Otogenetics Corporation
  • 24. Quest Diagnostics Inc.
  • 25. Thermo Fisher Scientific Inc.
  • 26. TRUE HEALTH LABS

LIST OF FIGURES

  • FIGURE 1. CARRIER SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. CARRIER SCREENING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARRIER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARRIER SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARRIER SCREENING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARRIER SCREENING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CARRIER SCREENING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CARRIER SCREENING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CARRIER SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CARRIER SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARRIER SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARRIER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARRIER SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARRIER SCREENING MARKET DYNAMICS
  • TABLE 7. GLOBAL CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARRIER SCREENING MARKET SIZE, BY CUSTOMIZED PANEL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARRIER SCREENING MARKET SIZE, BY PREDESIGNED PANEL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARRIER SCREENING MARKET SIZE, BY TARGETED DISEASE CARRIER SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARRIER SCREENING MARKET SIZE, BY HEMATOLOGICAL CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARRIER SCREENING MARKET SIZE, BY NEUROLOGICAL CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARRIER SCREENING MARKET SIZE, BY PULMONARY CONDITIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARRIER SCREENING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARRIER SCREENING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARRIER SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARRIER SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARRIER SCREENING MARKET SIZE, BY PHYSICIAN OFFICES & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CARRIER SCREENING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CARRIER SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM CARRIER SCREENING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM CARRIER SCREENING MARKET SIZE, BY EXPANDED CARRIER SCREENING, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM CARRIER SCREENING MARKET SIZE, BY MEDICAL CONDITION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CARRIER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CARRIER SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. CARRIER SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. CARRIER SCREENING MARKET, FPNV POSITIONING MATRIX, 2023